Related Experiment Video
Updated: Jun 27, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
OSTF1 knockdown mitigates IL-1β-induced chondrocyte injury via inhibiting the NF-κB signaling pathway
Bin Hu1, Gongwen Du2
1Department of Hand and Foot Surgery, Yijishan Hospital of Wannan Medical College, No. 2, Zheshan West Road, Wuhu, Anhui, China.
Abstract:
Osteoarthritis (OA) is an age-related joint disease characterized by progressive heterogeneous changes in articular cartilage and subchondral bone. Osteoclast stimulating factor 1 (OSTF1) is a small intracellular protein involved in bone formation and bone resorption. However, to our best knowledge, its role in OA is still unclear. In this study, an OA rat model was established by anterior cruciate ligament transection (ALCT). OSTF1 was increased in the cartilage tissues of OA patients and OA rats. Next, the role of OSTF1 in interleukin-1β (IL-1β)-induced chondrocyte apoptosis, inflammation and extracellular matrix degradation was explored through loss of function assays. Strikingly, OSTF1 knockdown relieved IL-1β-induced chondrocyte apoptosis, with decreased cleaved caspase-3 and cleaved PARP levels. Besides, OSTF1 knockdown restrained IL-1β-induced inflammation and degradation of extracellular matrix of chondrocytes. Subsequently, the molecular mechanism of OSTF1 was explored. Transcriptomic analysis revealed the potential gene network map regulated by OSTF1 knockdown. Some differentially expressed genes (DEGs) were involved in regulating the NF-κB signaling pathway. Furthermore, our results demonstrated that OSTF1 knockdown inhibited IL-1β-activated the NF-κB signaling pathway. Ultimately, we analyzed the potential gene network map regulated by OSTF1 and its downstream NF-κB. Bioinformatics analysis showed that 18 DEGs in OSTF1-silenced chondrocytes overlapped with the NF-κB downstream targets. Collectively, our findings indicate that OSTF1 knockdown mitigates IL-1β-induced chondrocyte injury via inhibiting the NF-κB signaling pathway.
Insights
Osteoclast stimulating factor 1 (OSTF1) is elevated in osteoarthritis. Reducing OSTF1 levels alleviates inflammation and cell death in chondrocytes by inhibiting the NF-κB signaling pathway, offering a potential therapeutic target for osteoarthritis.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Osteoarthritis (OA) is a degenerative joint disease with unclear molecular mechanisms.
- Osteoclast stimulating factor 1 (OSTF1), a protein involved in bone remodeling, has an unknown role in OA pathogenesis.
- Interleukin-1β (IL-1β) is a key inflammatory mediator in OA-induced chondrocyte damage.
Purpose of the Study:
- To investigate the role of OSTF1 in osteoarthritis.
- To elucidate the molecular mechanisms by which OSTF1 influences IL-1β-induced chondrocyte injury.
- To explore OSTF1's involvement in the NF-κB signaling pathway in OA.
Main Methods:
- Established an anterior cruciate ligament transection (ALCT) rat model for osteoarthritis.
- Quantified OSTF1 expression in human and rat cartilage tissues.
- Performed loss-of-function assays (OSTF1 knockdown) to assess effects on IL-1β-induced chondrocyte apoptosis, inflammation, and extracellular matrix degradation.
- Utilized transcriptomic analysis and bioinformatics to identify OSTF1-regulated genes and their overlap with NF-κB targets.
Main Results:
- OSTF1 expression was significantly increased in the cartilage of OA patients and OA rats.
- OSTF1 knockdown attenuated IL-1β-induced chondrocyte apoptosis, evidenced by reduced cleaved caspase-3 and cleaved PARP.
- OSTF1 knockdown inhibited IL-1β-induced inflammation and extracellular matrix degradation in chondrocytes.
- Transcriptomic analysis revealed OSTF1 regulates genes involved in the NF-κB signaling pathway, and OSTF1 knockdown suppressed IL-1β-activated NF-κB signaling.
- Bioinformatics analysis confirmed an overlap between OSTF1-regulated genes and NF-κB downstream targets.
Conclusions:
- OSTF1 plays a critical role in mediating IL-1β-induced chondrocyte injury in osteoarthritis.
- OSTF1 knockdown mitigates OA progression by inhibiting the NF-κB signaling pathway.
- Targeting OSTF1 presents a potential therapeutic strategy for managing osteoarthritis.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

